CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 98 enrolled
Drug / intervention
CRT-P OFF +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01559311
NCT01559311N/ACompleted
CompareCT.gov

Efficacy of the Presence of Right Ventricular Apical Pacing Induced Ventricular Dyssynchrony as a Guiding Parameter for Biventricular Pacing in Patients With Bradycardia and Normal Ejection Fraction

Abbott Medical Devices·interventional·Posted Mar 21, 2012·Updated Feb 4, 2019

In Brief

A clinical study evaluating CRT-P OFF, CRT-P ON, and 1 other intervention for Bradycardia. Completed, enrolled 98 participants across 7 sites in 5 countries.

Detailed Summary

The purpose of this clinical project is to evaluate the efficacy of the presence of Right Ventricular Apical (RVA) pacing induced ventricular dyssynchrony as a guiding parameter for bi-ventricular pacing in patients with bradycardia and normal left ventricular ejection fraction (LVEF). The results of this project may provide with the evidence based medicine for guidelines expansion of using Cardiac resynchronization therapy (CRT) in patients with Heart Block and normal LVEF (LVEF \>45%).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBradycardia
CountriesAustralia, China, India, Italy, Thailand
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 21, 2012
Enrollment StartFeb 1, 2012
Primary CompletionNov 1, 2015
Study CompletionApr 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 14.3 years ago

Interventions

CRT-P OFFdevice

CRT Pacemaker

CRT-P ONdevice

CRT Pacemaker

DDDRdevice

Dual-chamber, rate-modulated pacemaker